Dr. Lydia Usha MD
USINFO | 2013-11-28 14:45

Medical Oncologist

Contact Information
1725 W Harrison St
Suite 1010
Chicago, IL 60612
Phone: (312) 942-5904

Specialty & Clinical Interests
Medical Oncologist: General Oncology

Hospital Affiliation
Rush University Medical Center
High performing in Cancer

Education & Medical Training
California Pacific Medical Center Pacific
Residency, Internal Medicine, 1993 - 1997
University of Illinois College of Medicine at Chicago
Fellowship, Hematology/Oncology, 1997 - 2000
St Petersburg State Pediatric Medicine Academy
Class of 1982

Certifications & Licensure
American Board of Internal Medicine
Certified 2014 years in Internal Medicine
American Board of Internal Medicine
Certified 2014 years in Medical Oncology
IL State Medical License
Active through 2014

Awards, Honors & Recognition
CMS Stage 1 2012, Centers for Medicare & Medicaid Services
2011

Publications & Presentations
Biclonal breast carcinoma metastatic to a supraclavicular lymph node.
Cimbaluk, D., Usha, L., Siziopikou, K. P.
Effects of ERBB2 amplicon size and genomic alterations of chromosomes 1, 3, and 10 on patient response to trastuzumab in metastatic breast cancer.
Morrison, L. E., Jewell, S. S., Usha, L., Blondin, B. A., Rao, R. D., Tabesh, B., Kemper, M., Batus, M., Coon, J. S.
Topoisomerase II alpha gene copy loss has adverse prognostic significance in ERBB2-amplified breast cancer: a retrospective study of paraffin-embedded tumor specimens and medical charts.
Usha, L., Tabesh, B., Morrison, L. E., Rao, R. D., Jacobson, K., Zhu, A., Basu, S., Coon, J. S.
 
 

美闻网---美国生活资讯门户
©2012-2014 Bywoon | Bywoon